staurosporine aglycone has been researched along with Carcinoma, Large Cell in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Carcinoma, Large Cell: A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Odate, S | 1 |
| Onishi, H | 1 |
| Nakamura, K | 1 |
| Kojima, M | 1 |
| Uchiyama, A | 1 |
| Kato, M | 1 |
| Katano, M | 1 |
1 other study available for staurosporine aglycone and Carcinoma, Large Cell
| Article | Year |
|---|---|
Tropomyosin-related kinase B inhibitor has potential for tumor regression and relapse prevention in pulmonary large cell neuroendocrine carcinoma.
Topics: Animals; Brain-Derived Neurotrophic Factor; Carbazoles; Carcinoma, Large Cell; Carcinoma, Neuroendoc | 2013 |